Evaluation of cost-effective strategies for rabies post-exposure vaccination in low-income countries.

<h4>Background</h4>Prompt post-exposure prophylaxis (PEP) is essential in preventing the fatal onset of disease in persons exposed to rabies. Unfortunately, life-saving rabies vaccines and biologicals are often neither accessible nor affordable, particularly to the poorest sectors of soc...

Full description

Bibliographic Details
Main Authors: Katie Hampson, Sarah Cleaveland, Deborah Briggs
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2011-03-01
Series:PLoS Neglected Tropical Diseases
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21408121/?tool=EBI
_version_ 1818905308220620800
author Katie Hampson
Sarah Cleaveland
Deborah Briggs
author_facet Katie Hampson
Sarah Cleaveland
Deborah Briggs
author_sort Katie Hampson
collection DOAJ
description <h4>Background</h4>Prompt post-exposure prophylaxis (PEP) is essential in preventing the fatal onset of disease in persons exposed to rabies. Unfortunately, life-saving rabies vaccines and biologicals are often neither accessible nor affordable, particularly to the poorest sectors of society who are most at risk and upon whom the largest burden of rabies falls. Increasing accessibility, reducing costs and preventing delays in delivery of PEP should therefore be prioritized.<h4>Methodology/principal findings</h4>We analyzed different PEP vaccination regimens and evaluated their relative costs and benefits to bite victims and healthcare providers. We found PEP vaccination to be an extremely cost-effective intervention (from $200 to less than $60/death averted). Switching from intramuscular (IM) administration of PEP to equally efficacious intradermal (ID) regimens was shown to result in significant savings in the volume of vaccine required to treat the same number of patients, which could mitigate vaccine shortages, and would dramatically reduce the costs of implementing PEP. We present financing mechanisms that would make PEP more affordable and accessible, could help subsidize the cost for those most in need, and could even support new and existing rabies control and prevention programs.<h4>Conclusions/significance</h4>We conclude that a universal switch to ID delivery would improve the affordability and accessibility of PEP for bite victims, leading to a likely reduction in human rabies deaths, as well as being economical for healthcare providers.
first_indexed 2024-12-19T21:21:16Z
format Article
id doaj.art-ea499468232946dd901bf976eb8e1f47
institution Directory Open Access Journal
issn 1935-2727
1935-2735
language English
last_indexed 2024-12-19T21:21:16Z
publishDate 2011-03-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Neglected Tropical Diseases
spelling doaj.art-ea499468232946dd901bf976eb8e1f472022-12-21T20:05:13ZengPublic Library of Science (PLoS)PLoS Neglected Tropical Diseases1935-27271935-27352011-03-0153e98210.1371/journal.pntd.0000982Evaluation of cost-effective strategies for rabies post-exposure vaccination in low-income countries.Katie HampsonSarah CleavelandDeborah Briggs<h4>Background</h4>Prompt post-exposure prophylaxis (PEP) is essential in preventing the fatal onset of disease in persons exposed to rabies. Unfortunately, life-saving rabies vaccines and biologicals are often neither accessible nor affordable, particularly to the poorest sectors of society who are most at risk and upon whom the largest burden of rabies falls. Increasing accessibility, reducing costs and preventing delays in delivery of PEP should therefore be prioritized.<h4>Methodology/principal findings</h4>We analyzed different PEP vaccination regimens and evaluated their relative costs and benefits to bite victims and healthcare providers. We found PEP vaccination to be an extremely cost-effective intervention (from $200 to less than $60/death averted). Switching from intramuscular (IM) administration of PEP to equally efficacious intradermal (ID) regimens was shown to result in significant savings in the volume of vaccine required to treat the same number of patients, which could mitigate vaccine shortages, and would dramatically reduce the costs of implementing PEP. We present financing mechanisms that would make PEP more affordable and accessible, could help subsidize the cost for those most in need, and could even support new and existing rabies control and prevention programs.<h4>Conclusions/significance</h4>We conclude that a universal switch to ID delivery would improve the affordability and accessibility of PEP for bite victims, leading to a likely reduction in human rabies deaths, as well as being economical for healthcare providers.https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21408121/?tool=EBI
spellingShingle Katie Hampson
Sarah Cleaveland
Deborah Briggs
Evaluation of cost-effective strategies for rabies post-exposure vaccination in low-income countries.
PLoS Neglected Tropical Diseases
title Evaluation of cost-effective strategies for rabies post-exposure vaccination in low-income countries.
title_full Evaluation of cost-effective strategies for rabies post-exposure vaccination in low-income countries.
title_fullStr Evaluation of cost-effective strategies for rabies post-exposure vaccination in low-income countries.
title_full_unstemmed Evaluation of cost-effective strategies for rabies post-exposure vaccination in low-income countries.
title_short Evaluation of cost-effective strategies for rabies post-exposure vaccination in low-income countries.
title_sort evaluation of cost effective strategies for rabies post exposure vaccination in low income countries
url https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21408121/?tool=EBI
work_keys_str_mv AT katiehampson evaluationofcosteffectivestrategiesforrabiespostexposurevaccinationinlowincomecountries
AT sarahcleaveland evaluationofcosteffectivestrategiesforrabiespostexposurevaccinationinlowincomecountries
AT deborahbriggs evaluationofcosteffectivestrategiesforrabiespostexposurevaccinationinlowincomecountries